Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(GLAXO) Glaxosmithkline Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Pharmaceuticals | (GLAXO) share price targets

Complete technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Glaxosmithkline Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2025-03-27 View latest technical analysis

10 day averaged volume of Glaxosmithkline Pharmaceuticals is 129849

Date	Daily Closing Price	Open	High	Low	Volume
27 Thu Mar 2025	2836.90	2819.25	2850.85	2772.90	0.595 times
26 Wed Mar 2025	2818.45	2834.30	2909.60	2790.00	0.884 times
25 Tue Mar 2025	2834.30	2877.00	2888.90	2790.00	0.886 times
24 Mon Mar 2025	2882.95	2959.00	2988.00	2860.80	0.512 times
21 Fri Mar 2025	2935.65	2861.00	2968.90	2839.35	1.375 times
20 Thu Mar 2025	2860.50	2850.00	2921.20	2832.05	1.107 times
19 Wed Mar 2025	2838.30	2799.95	2845.00	2767.80	0.983 times
18 Tue Mar 2025	2795.15	2693.45	2810.95	2677.20	1.244 times
17 Mon Mar 2025	2693.45	2657.80	2730.00	2650.00	0.774 times
13 Thu Mar 2025	2657.80	2690.00	2695.10	2640.05	0.478 times

My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 2845.7 as stoploss in an intra day sell trade for a target of 2727.64. However, stock will show a bullish move above 2845.7.

Share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Target	1921.00
Downside Target	1961.55
Downside Target	2158.40
Downside Target	2272.00
Downside Target	2390.05
Downside Target	2446.00
Downside Target	2605.45
Downside Target	2742.95
Downside Target	2772.90
Downside Target	2780.00
Downside Target	2798.20
Upside Target	2968.90
Upside Target	2988.00

Intraday share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Intraday Target	2743.87
Downside Intraday Target	2650.83
Upside Intraday Target	2958.97
Upside Intraday Target	3081.03
Upside Intraday Target	2865.93

Weekly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Weekly Closing Price	Open	High	Low	Volume
27 Thu Mar 2025	2836.90	2959.00	2988.00	2772.90	0.525 times
21 Fri Mar 2025	2935.65	2657.80	2968.90	2650.00	1.231 times
13 Thu Mar 2025	2657.80	2748.00	2798.20	2605.45	0.456 times
07 Fri Mar 2025	2751.60	2485.00	2780.00	2390.05	0.681 times
28 Fri Feb 2025	2475.35	2446.00	2673.00	2446.00	0.192 times

Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Monthly Closing Price	Open	High	Low	Volume
27 Thu Mar 2025	2836.90	2485.00	2988.00	2390.05	0.179 times
28 Fri Feb 2025	2475.35	1955.95	2744.95	1921.00	5.762 times
31 Fri Jan 2025	1977.15	2235.00	2272.00	1961.55	1.617 times
31 Tue Dec 2024	2251.85	2436.00	2457.75	2158.40	0.973 times

Scroll below to view daily charts

Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Glaxosmithkline Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.

MACD generated a SELL signal for Glaxosmithkline Pharmaceuticals in short term but the sell signal is initial and weak.

Glaxosmithkline Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up

CCI has generated a SELL signal for Glaxosmithkline Pharmaceuticals in short term but SELL signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Glaxosmithkline Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2827.81 and Glaxosmithkline Pharmaceuticals (GLAXO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Glaxosmithkline Pharmaceuticals (GLAXO) stock. Volume based technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) stock is negative.

Glaxosmithkline Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.